Gabriele M. Cerrone, Director, 10% Owner at Accustem Sciences Inc. (ACUT), bought 3,729 shares at $1.42 ($5K) on 2022-12-02, disclosed to the SEC on 2022-12-05.
Open-market purchase of $5k ACUT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ACUT | BUY | 2025-04-10 | $25K | — | Filing → |
| ACUT | BUY | 2025-04-08 | $79K | — | Filing → |
| ACUT | BUY | 2025-01-03 | $38K | — | Filing → |